n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with dacarbazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, NM; Hagemeister, FB; Liang, JC; Sen, P | 1 |
Nagane, M | 1 |
1 review(s) available for n-(2-chloroethyl)-n-nitrosoacetamide and dacarbazine
Article | Year |
---|---|
[Chemotherapy for malignant gliomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Glioma; Humans; Nitroso Compounds; Survival Rate; Temozolomide; Tumor Suppressor Proteins | 2007 |
1 other study(ies) available for n-(2-chloroethyl)-n-nitrosoacetamide and dacarbazine
Article | Year |
---|---|
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazine; DNA Damage; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Nitroso Compounds; Prednisone; Procarbazine; Sister Chromatid Exchange; Vinblastine; Vincristine | 1990 |